首页> 美国卫生研究院文献>American Journal of Translational Research >The effect of Bailing capsules combined with losartan to treat diabetic glomerulosclerosis and the combination’s effect on blood and urine biochemistry
【2h】

The effect of Bailing capsules combined with losartan to treat diabetic glomerulosclerosis and the combination’s effect on blood and urine biochemistry

机译:百分籽胶囊结合氯沙坦治疗糖尿病肾小球粥样硬化的影响及对血液和尿生物化学的影响

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Objective: This study aimed to explore the efficacy of Bailing capsules combined with losartan to treat diabetic glomerulosclerosis (DG) and the combination’s effect on blood and urine biochemistry. Methods: 160 DG patients admitted to our hospital were recruited as the study cohort and randomly divided into a control group and an observation group (n=80 in each group). The control group was treated with losartan, and the observation group was treated with losartan and Bailing capsules. The efficacy, diastolic blood pressure (DBP), systolic blood pressure (SBP), blood creatinine (Scr), 24 h urine protein (24 h UP), blood urea nitrogen (BUN), urine microalbumin (mALB), urine β2 microglobulin (β2-MG), glomerular filtration rates (GFR), TCM scores, serum superoxide dismutase (SOD), reactive oxygen species (ROS), 8-hydroxydeoxyguanine (8-OHdG), hypersensitive C-reactive protein (hs-CRP), transforming growth factor β1 (TGF-β1), and the serum amyloid A (SAA) levels were compared between the two groups. Results: The overall effective rate was higher in the observation group (91.25%) than it was in the control group (78.75%) (P<0.05). After the treatment, the DBP, SBP, Scr, 24 h UP, BUN, mALB, and β2-MG levels were lower, and the GFR was higher in the observation group than in the control group (P<0.01). The TCM points were lower in the observation group than they were in the control group (P<0.01). The observation group also showed higher serum SOD and lower ROS, 8-OHdG, hs-CRP, TGF-β1, and SAA levels than the control group (P<0.01). The differences in the incidences of adverse reactions between the two groups were not significantly different (P>0.05). Conclusion: Bailing capsules combined with losartan in the treatment of diabetic glomerulosclerosis can improve the therapeutic efficacy, improve the blood and urine biochemical indexes, the renal function, and the clinical symptoms, reduce the oxidative stress, improve the microinflammatory state, and delay the progression of the disease without increasing the adverse reactions.
机译:目的:这项研究旨在探讨戒断胶囊联合氯沙坦治疗糖尿病肾硬化(DG)的疗效,以及组合对血液和尿生物化学的影响。方法:招募160例患者,作为研究队列,随机分为对照组和观察组(每组N = 80)。对照组用氯沙坦处理,用氯沙坦和蜂拥而膜胶囊处理观察组。疗效,舒张压(DBP),收缩压(SBP),血肌酐(SCR),24小时尿蛋白(24 H升),血尿尿素氮(BUN),尿β2微球蛋白,尿β2微球蛋白( β2-mg),肾小球过滤速率(GFR),TCM评分,血清超氧化物歧化酶(SOD),反应性氧物质(ROS),8-羟基氧杂体(8-OHDG),过敏的C-反应蛋白(HS-CRP),转化在两组之间比较了生长因子β1(TGF-β1)和血清淀粉样蛋白A(SAA)水平。结果:观察组(91.25%)的总体有效率高于对照组(78.75%)(P <0.05)。治疗后,DBP,SBP,SCR,24 H UP,BUN,MALB和β2-Mg水平较低,观察组的GFR高于对照组(P <0.01)。观察组中的TCM点低于对照组(P <0.01)。观察组还显示出高于对照组的血清SOD和下ROS,8-OHDG,HS-CRP,TGF-β1和SAA水平(P <0.01)。两组之间不良反应发生差异的差异没有显着差异(p> 0.05)。结论:保释胶囊联合氯沙坦治疗糖尿病肾小球粥样硬化可以提高治疗疗效,改善血液和尿液生化指标,肾功能和临床症状,降低氧化应激,提高微炎症状态,延迟进展疾病而不增加不良反应。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号